Potentiation of hemolytic plaque formation by incubation of immunized spleen cells in phenothiazine derivatives.
D000818:Animals; D000917:Antibody Formation; D002463:Cell Membrane Permeability / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology*; D004912:Erythrocytes; D006460:Hemolysin Proteins; D006461:Hemolysis; D046911:Macromolecular Substances; D008297:Male; D010640:Phenothiazines / Q000494:pharmacology*; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D013154:Spleen / Q000166:cytology*; D013881:Thioridazine / Q000494:pharmacology
D006460:Hemolysin Proteins; D046911:Macromolecular Substances; D010640:Phenothiazines; D011398:Promethazine; D013881:Thioridazine; D002746:Chlorpromazine